Copyright
©The Author(s) 2025.
World J Clin Pediatr. Dec 9, 2025; 14(4): 107974
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.107974
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.107974
| Sepsis type | Common pathogens |
| Early-onset sepsis | Group B Streptococcus, Escherichia coli, Listeria monocytogenes |
| Late-onset sepsis | Klebsiella pneumoniae, Staphylococcus aureus, Candida spp. |
| Pediatric sepsis | Pseudomonas aeruginosa, Enterobacter spp., MRSA |
| Region/Condition | Neonatal sepsis - common pathogens | Pediatric sepsis - common pathogens |
| Developed countries | Group B Streptococcus, Escherichia coli, Listeria spp. | Streptococcus pneumoniae, Neisseria meningitidis, MRSA |
| Developing countries | Klebsiella pneumoniae, Acinetobacter baumannii, Escherichia coli | Salmonella spp., Staphylococcus aureus, Pseudomonas aeruginosa |
| NICU/PICU settings | MDR Klebsiella, Candida albicans, Enterococcus spp. | Acinetobacter, Stenotrophomonas maltophilia |
| Immunocompromised children | Pseudomonas aeruginosa, Candida parapsilosis | Nocardia, Fusarium, Aspergillus, MDR GNB |
Table 3 Traditional vs emerging diagnostic techniques for neonatal and pediatric sepsis[48]
| Diagnostic method | Turnaround time | Sensitivity/Specificity | Key advantages | Limitations |
| Blood culture | 48-72 hours | Moderate | Gold standard, organism isolation | Low yield in neonates, slow |
| C-reactive protein | < 6 hours | Low-moderate | Widely available | Non-specific |
| Procalcitonin | < 6 hours | Moderate-high | Early rise in bacterial infections | Cost, variation by age |
| PCR-based panels | 1-3 hours | High | Pathogen-specific, rapid results | Limited panels, cost |
| Next-generation sequencing | 24-48 hours | High | Broad-range, detects rare pathogens | Expensive, needs expertise |
| Artificial intelligence-driven tools | Real-time | Evolving | Integration with clinical data | Limited pediatric validation |
- Citation: Nagoba BS, Dhotre SV, Sonar MN, Mumbre SS, Gavkare AM, Dhotre PS. Neonatal and pediatric sepsis: Microbiological insights, diagnostic innovations, and antimicrobial challenges. World J Clin Pediatr 2025; 14(4): 107974
- URL: https://www.wjgnet.com/2219-2808/full/v14/i4/107974.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v14.i4.107974
